{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.75, "epsForward": -0.73, "epsCurrentYear": -1.57, "priceEpsCurrentYear": -1.133758, "sharesOutstanding": 111810000, "bookValue": -0.508, "fiftyDayAverage": 1.66563, "fiftyDayAverageChange": 0.11436999, "fiftyDayAverageChangePercent": 0.0686647, "twoHundredDayAverage": 2.372985, "twoHundredDayAverageChange": -0.5929849, "twoHundredDayAverageChangePercent": -0.24988988, "marketCap": 214192736, "forwardPE": -2.4383562, "priceToBook": -3.5039368, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.8 - Buy", "tradeable": false, "cryptoTradeable": false, "currency": "EUR", "financialCurrency": "USD", "regularMarketOpen": 1.78, "averageDailyVolume3Month": 391, "averageDailyVolume10Day": 2000, "fiftyTwoWeekLowChange": 0.29250002, "fiftyTwoWeekLowChangePercent": 0.19663867, "fiftyTwoWeekRange": "1.4875 - 4.106", "fiftyTwoWeekHighChange": -2.326, "fiftyTwoWeekHighChangePercent": -0.5664881, "fiftyTwoWeekLow": 1.4875, "fiftyTwoWeekHigh": 4.106, "earningsTimestamp": 1683806400, "earningsTimestampStart": 1691584200, "earningsTimestampEnd": 1692016200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1521702000000, "priceHint": 4, "marketState": "REGULAR", "regularMarketChange": 0.27999997, "regularMarketTime": 1683874419, "regularMarketDayHigh": 1.78, "regularMarketDayRange": "1.78 - 1.78", "regularMarketDayLow": 1.78, "regularMarketVolume": 20000, "regularMarketPreviousClose": 1.5, "bid": 1.786, "ask": 1.856, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "regularMarketChangePercent": 18.666664, "regularMarketPrice": 1.78, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "FRA", "shortName": "OPTINOSE INC.  DL-,001", "longName": "OptiNose, Inc.", "messageBoardId": "finmb_252053415", "market": "dr_market", "symbol": "0OP.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "1020 Stony Hill Road", "address2": "Suite 300", "city": "Yardley", "state": "PA", "zip": "19067", "country": "United States", "phone": "267 364 3500", "fax": "267 395 2119", "website": "https://www.optinose.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. OptiNose, Inc. has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Orexia Therapeutics to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania.", "fullTimeEmployees": 141, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ramy A. Mahmoud M.D., M.P.H.", "age": 57, "title": "CEO & Director", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 731587, "fmt": "731.59k", "longFmt": "731,587"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael F. Marino Esq.", "age": 46, "title": "Chief Legal Officer & Corp. Sec.", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 604237, "fmt": "604.24k", "longFmt": "604,237"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Anthony J. Krick", "age": 41, "title": "VP & Chief Accounting Officer", "yearBorn": 1981, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jonathan  Neely", "title": "VP of Investor Relations & Bus. Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Karen E. Brophy", "age": 59, "title": "Chief HR Officer & VP of HR", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul  Spence", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 5, "boardRisk": 5, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}